Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;29:822-827

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mervaala, E. M.A.
Right arrow Articles by Karppanen, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mervaala, E. M.A.
Right arrow Articles by Karppanen, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYCLOSPORIN A
*MAGNESIUM COMPOUNDS
*MAGNESIUM, ELEMENTAL
Medline Plus Health Information
*Dietary Sodium
*High Blood Pressure
*Kidney Diseases

(Hypertension. 1997;29:822-827.)
© 1997 American Heart Association, Inc.


Articles

Effects of Dietary Sodium and Magnesium on Cyclosporin A–Induced Hypertension and Nephrotoxicity in Spontaneously Hypertensive Rats

Eero M.A. Mervaala; Anna-Kaisa Pere; Leena Lindgren; Juha Laakso; Terttu-Liisa Teravainen; Kirsi Karjala; Heikki Vapaatalo; Juhani Ahonen; Heikki Karppanen

the Institute of Biomedicine, Department of Pharmacology and Toxicology, University of Helsinki (E.M.A.M., J.L., T.-L.T., K.K., H.V., H.K.); the Division of Transplantation Surgery, Fourth Department of Surgery, Helsinki University Central Hospital (A.-K.P., L.L., J.A.); Mila Ltd (J.L.); and the Department of Physiology, Faculty of Veterinary Medicine, University of Helsinki (T.-L.T.), Finland.

Correspondence to Eero Mervaala, MD, PhD, Institute of Biomedicine, Department of Pharmacology and Toxicology, PO Box 8, FIN-00014 University of Helsinki, Finland. E-mail eero.mervaala@helsinki.fi

Arterial hypertension, nephrotoxicity, and magnesium loss are common side effects of the immunosuppressive agent cyclosporin A (CsA). In the present study, the effects of dietary sodium and magnesium on CsA toxicity were examined in spontaneously hypertensive rats. A 6-week treatment with CsA during a moderately low-sodium diet (Na 0.3%, Mg 0.2% of the dry weight of the chow) raised blood pressure only slightly, without evidence of nephrotoxicity. By contrast, CsA during a high-sodium diet (Na 2.6%) produced a pronounced rise in blood pressure as well as marked nephrotoxicity, comprising decreased creatinine clearance, increased levels of serum creatinine and urea, and increased urinary protein excretion. During the high-sodium diet, CsA decreased myocardial and bone magnesium concentration and increased myocardial and renal calcium concentration. Magnesium supplementation (Mg 0.6%) protected against the CsA-induced hypertension and nephrotoxicity during the high-sodium diet. Magnesium supplementation also completely prevented the CsA-induced myocardial magnesium depletion and calcium accumulation in the heart and kidney during the high-sodium diet. Our findings indicate a detrimental interaction between increased sodium intake and CsA treatment and a marked protection by concomitant oral magnesium supplementation.


Key Words: cyclosporine • rats, spontaneously hypertensive • hypertrophy, left ventricular • proteinuria • sodium • magnesium • calcium




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. M. Touyz
Transient receptor potential melastatin 6 and 7 channels, magnesium transport, and vascular biology: implications in hypertension
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1103 - H1118.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
W. Zhang
Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy
Cardiovasc Res, February 1, 2002; 53(2): 294 - 303.
[Abstract] [Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
C. L. Baum
Weight Gain and Cardiovascular Risk After Organ Transplantation
JPEN J Parenter Enteral Nutr, May 1, 2001; 25(3): 114 - 119.
[Abstract] [PDF]


Home page
HypertensionHome page
Z. J. Cheng, T. Vaskonen, I. Tikkanen, K. Nurminen, H. Ruskoaho, H. Vapaatalo, D. Muller, J.-K. Park, F. C. Luft, and E. M. A. Mervaala
Endothelial Dysfunction and Salt-Sensitive Hypertension in Spontaneously Diabetic Goto-Kakizaki Rats
Hypertension, February 1, 2001; 37(2): 433 - 439.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. Mervaala, D. N. Muller, J.-K. Park, R. Dechend, F. Schmidt, A. Fiebeler, M. Bieringer, V. Breu, D. Ganten, H. Haller, et al.
Cyclosporin A Protects Against Angiotensin II-Induced End-Organ Damage in Double Transgenic Rats Harboring Human Renin and Angiotensinogen Genes
Hypertension, January 1, 2000; 35(1): 360 - 366.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. Zhang, R. C. Kowal, F. Rusnak, R. A. Sikkink, E. N. Olson, and R. G. Victor
Failure of Calcineurin Inhibitors to Prevent Pressure-Overload Left Ventricular Hypertrophy in Rats
Circ. Res., April 2, 1999; 84(6): 722 - 728.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J.-W. Gu, V. Anand, E. W. Shek, M. C. Moore, A. L. Brady, W. C. Kelly, and T. H. Adair
Sodium Induces Hypertrophy of Cultured Myocardial Myoblasts and Vascular Smooth Muscle Cells
Hypertension, May 1, 1998; 31(5): 1083 - 1087.
[Abstract] [Full Text] [PDF]